Follow
Vladimir Ponomarev
Title
Cited by
Cited by
Year
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
AJ Minn, Y Kang, I Serganova, GP Gupta, DD Giri, M Doubrovin, ...
The Journal of clinical investigation 115 (1), 44-55, 2005
9392005
Senolytic CAR T cells reverse senescence-associated pathologies
C Amor, J Feucht, J Leibold, YJ Ho, C Zhu, D Alonso-Curbelo, ...
Nature 583 (7814), 127-132, 2020
5912020
T cell–encoded CD80 and 4-1BBL induce auto-and transcostimulation, resulting in potent tumor rejection
MT Stephan, V Ponomarev, RJ Brentjens, AH Chang, KV Dobrenkov, ...
Nature medicine 13 (12), 1440-1449, 2007
3842007
A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging
V Ponomarev, M Doubrovin, I Serganova, J Vider, A Shavrin, T Beresten, ...
European journal of nuclear medicine and molecular imaging 31, 740-751, 2004
3542004
Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo
M Doubrovin, V Ponomarev, T Beresten, J Balatoni, W Bornmann, R Finn, ...
Proceedings of the National Academy of Sciences 98 (16), 9300-9305, 2001
2762001
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
G Koehne, M Doubrovin, E Doubrovina, P Zanzonico, HF Gallardo, ...
Nature biotechnology 21 (4), 405-413, 2003
2612003
NF-κB is essential for the progression of KSHV-and EBV-infected lymphomas in vivo
SA Keller, D Hernandez-Hopkins, J Vider, V Ponomarev, E Hyjek, ...
Blood 107 (8), 3295-3302, 2006
2252006
Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice
I Serganova, M Doubrovin, J Vider, V Ponomarev, S Soghomonyan, ...
Cancer Research 64 (17), 6101-6108, 2004
2002004
Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo
V Ponomarev, M Doubrovin, C Lyddane, T Beresten, J Balatoni, ...
Neoplasia 3 (6), 480-488, 2001
1882001
Multimodality in vivo molecular-genetic imaging
M Doubrovin, I Serganova, P Mayer-Kuckuk, V Ponomarev, RG Blasberg
Bioconjugate chemistry 15 (6), 1376-1388, 2004
1742004
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
T Dao, D Pankov, A Scott, T Korontsvit, V Zakhaleva, Y Xu, J Xiang, S Yan, ...
Nature biotechnology 33 (10), 1079-1086, 2015
1712015
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
C Kaittanis, C Andreou, H Hieronymus, N Mao, CA Foss, M Eiber, ...
Journal of experimental medicine 215 (1), 159-175, 2018
1462018
Human reporter genes: potential use in clinical studies
I Serganova, V Ponomarev, R Blasberg
Nuclear medicine and biology 34 (7), 791-807, 2007
1392007
Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo
E Henke, J Perk, J Vider, P De Candia, Y Chin, DB Solit, V Ponomarev, ...
Nature biotechnology 26 (1), 91-100, 2008
1382008
Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape–driven relapse in multiple myeloma
C Fernández de Larrea, M Staehr, AV Lopez, KY Ng, Y Chen, ...
Blood cancer discovery 1 (2), 146-154, 2020
1272020
A human-derived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2
V Ponomarev, M Doubrovin, A Shavrin, I Serganova, T Beresten, ...
Journal of Nuclear Medicine 48 (5), 819-826, 2007
1162007
Monitoring the Efficacy of Adoptively Transferred Prostate Cancer–Targeted Human T Lymphocytes with PET and Bioluminescence Imaging
K Dobrenkov, M Olszewska, Y Likar, L Shenker, G Gunset, S Cai, ...
Journal of Nuclear Medicine 49 (7), 1162-1170, 2008
1072008
In vivo bioluminescence tomography with a blocking‐off finite‐difference method and MRI/CT coregistration
AD Klose, BJ Beattie, H Dehghani, L Vider, C Le, V Ponomarev, ...
Medical physics 37 (1), 329-338, 2010
892010
Enhancement of PSMA-directed CAR adoptive immunotherapy by PD-1/PD-L1 blockade
I Serganova, E Moroz, I Cohen, M Moroz, M Mane, J Zurita, L Shenker, ...
Molecular Therapy-Oncolytics 4, 41-54, 2017
882017
Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model
A Labrinidis, S Hay, V Liapis, V Ponomarev, DM Findlay, A Evdokiou
Clinical cancer research 15 (10), 3451-3461, 2009
852009
The system can't perform the operation now. Try again later.
Articles 1–20